Hudson Bay Capital Management »

C4 Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $213k 112k 1.91
2025-06-30 $23k 16k 1.43

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding C4 Therapeutics

Point72 Asset Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
OrbiMed Advisors
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Millennium Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Geode Capital Management
Jane Street

View all funds holding C4 Therapeutics